Remove Board-Certified Remove Education Remove Government Remove Healthcare
article thumbnail

Rheumatology Board Meeting Summary | Spring 2025

ABIM

Salahuddin Kazi, MD, Chair, Rheumatology Board The Rheumatology Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on March 11, 2025. ABIM and the Rheumatology Board gratefully acknowledge the service of Susan K.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

Erin Bonura, MD, Chair, ABIM Infectious Disease Board The Infectious Disease Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on March 25, 2025. JD , whose terms on the Specialty Board end June 30, 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hematology Board Meeting Summary | Spring 2025

ABIM

Gertz, MD, MACP, Chair, ABIM Hematology Board The Hematology Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on May 2, 2025. The group discussed policy shifts and potential implications for graduate medical education and health equity.

article thumbnail

Improving Nursing Home Quality: Jasmine Travers, Alice Bonner, Isaac Longobardi, and Mike Wasserman

GeriPal

There have been multiple subsequent government reports on nursing home care, most recently was about eight, nine years ago from the OIG. Part of it’s what Mike was saying, it’s accountability as a country, as a nation and as the government. This is a problem that’s existed for decades. What are they accountable for?

Finance 95
article thumbnail

Telemedicine in a Post-Pandemic World: Joe Rotella, Brooke Calton, Carly Zapata

GeriPal

Because pre-pandemic, right, there was issues with you had to be boarded in the state, right? ” And I could tell you that’s a lot for a government agency to hear. I would expect that the DEA or the state medical boards would be looking at volumes of prescriptions. Eric: Well, let me ask you this. Did you query it?